Allero Therapeutics is a Dutch biotech company that develops next generation immunotherapies for immune mediated disorders. Our goal is to develop novel targeted treatments that induce long-lasting antigen-specific tolerance. Our proprietary SOMIT (Specific Oromucosal Immunotherapy) technology combines a tolerance-inducing agent with novel oral patch mediated targeted delivery of specific antigens to the oral mucosa immune privilege.
View Top Employees from Allero TherapeuticsWebsite | http://www.allerotherapeutics.com |
Employees | 5 (2 on RocketReach) |
Founded | 2019 |
Technologies |
JavaScript,
HTML,
Twitter
+7 more
(view full list)
|
Industry | Biotechnology Research, Biotechnology, Science and Engineering, Pharmaceutical, Health Care |
Looking for a particular Allero Therapeutics employee's phone or email?
Kees Leenhouts is the Co-Founder and Chief Technology Officer and Chief Operations Officer of Allero Therapeutics.
2 people are employed at Allero Therapeutics.